Viewing Study NCT01743157


Ignite Creation Date: 2025-12-24 @ 7:04 PM
Ignite Modification Date: 2026-02-10 @ 2:26 PM
Study NCT ID: NCT01743157
Status: COMPLETED
Last Update Posted: 2013-08-29
First Post: 2011-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma
Sponsor: California Pacific Medical Center Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
Keywords: